Trials / Unknown
UnknownNCT06268470
Antiplatelet Therapy in Chronic Urticaria
Efficacy of Antiplatelet Therapy for the Treatment of Chronic Recalcitrant Urticaria
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 12 (estimated)
- Sponsor
- Chulalongkorn University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This study compares the combination of antiplatelets and antihistamine versus antihistamine alone for the treatment of chronic spontaneous urticaria
Detailed description
This study is a randomized control trial comparing the effectiveness of the combination of antiplatelets and antihistamine and antihistamine alone for the treatment of chronic spontaneous urticaria
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Desloratadine plus cilostazol and dipyridamole | Desloratadine 20 mg/day plus cilostazol 150 mg/day and dipyridamole 50 mg/day |
| DRUG | Desloratadine | Desloratadine 20 mg/day |
Timeline
- Start date
- 2018-06-01
- Primary completion
- 2024-03-01
- Completion
- 2024-05-01
- First posted
- 2024-02-20
- Last updated
- 2024-02-21
Locations
1 site across 1 country: Thailand
Source: ClinicalTrials.gov record NCT06268470. Inclusion in this directory is not an endorsement.